{"id":"W4309425609","doi":"10.1016/j.ahj.2022.11.015","title":"Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial","year":2022,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Blood transfusion and management","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Institut Universitaire de Gériatrie de Montréal; Ottawa Hospital; University of Alberta; Canadian VIGOUR Centre; University of Toronto; St. Michael's Hospital","funders":"Duke Clinical Research Institute; National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; Esperion Therapeutics; GlaxoSmithKline; HLS Therapeutics; Daiichi Sankyo Europe; Servier; University of Toronto; Agence Nationale de la Recherche; Novo Nordisk; Daiichi-Sankyo; Cerus Corporation; Canadian Blood Services; ReCor Medical; AstraZeneca; Amarin Corporation; Regeneron Pharmaceuticals; Boston Scientific Corporation; Pfizer; York University; Bristol-Myers Squibb; Eli Lilly and Company; Institute of Circulatory and Respiratory Health; CSL Behring; Heart and Stroke Foundation of Canada; Sanofi; MicroPort; Amgen","keywords":"Medicine; Unstable angina; Myocardial infarction; Clinical trial; Randomized controlled trial; Hemoglobin; Angina; Internal medicine; Intensive care medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004567222,0.00009206987,0.0005153028,0.0000546731,0.000558807,0.00003519436,0.00004614208,0.00001831048,0.0001626511],"category_scores_gemma":[0.0002885549,0.00005870781,0.0002784509,0.000091112,0.000323909,0.0000333031,0.00003048793,0.0003807737,7.400886e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001590885,"about_ca_system_score_gemma":0.0001388422,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003310083,"about_ca_topic_score_gemma":0.000002005253,"domain_scores_codex":[0.9983512,0.0006144281,0.0004318664,0.0001695351,0.0002859121,0.0001471235],"domain_scores_gemma":[0.9975116,0.002106455,0.00009332873,0.00009828104,0.0000427046,0.0001476179],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8557487,0.0002984164,0.0005928782,0.00001318882,0.0006020297,0.0000161665,0.0007225307,0.00003728452,0.0008187104,0.0002821471,0.0390336,0.1018344],"study_design_scores_gemma":[0.7353301,0.003701226,0.001311622,0.00001192702,0.001035733,0.0007965897,0.001711226,0.002283321,0.00008377147,0.0002141759,0.2533866,0.0001336781],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8153169,0.00163422,0.1016432,0.07149208,0.001356447,0.008260737,0.00001166906,0.00003651375,0.000248251],"genre_scores_gemma":[0.9663363,0.005979075,0.01288755,0.01207225,0.00147482,0.0007041174,0.000006475462,0.00003086816,0.0005085091],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2143531,"threshold_uncertainty_score":0.4297948,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06176637577081637,"score_gpt":0.354774876570172,"score_spread":0.2930085007993557,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}